MedPath
HSA Approval

BECAVIR F.C. TABLET 0.5 mg

SIN15955P

BECAVIR F.C. TABLET 0.5 mg

BECAVIR F.C. TABLET 0.5 mg

June 15, 2020

EURO ASIA MEDICO PTE. LTD.

EURO ASIA MEDICO PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantEURO ASIA MEDICO PTE. LTD.
Licence HolderEURO ASIA MEDICO PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

J05AF10

entecavir

Manufacturer Information

EURO ASIA MEDICO PTE. LTD.

UBI Pharma Inc (Hsinchu Plant)

Active Ingredients

Entecavir Monohydrate eqv Entecavir

0.5 mg

Entecavir

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BECAVIR F.C. TABLET 0.5 mg - HSA Approval | MedPath